stockrowTeva Pharmaceutical Industries Ltd.
TEVA Healthcare Drug Manufacturers Specialty & Generic
Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.
- Revenue
- −1.90%
- EPS
- −47.2%
- Free cash flow
- −30.3%
- Total debt
- −0.43%
Quarter to September 2026, against a year earlier
Follow TEVA
Alert me
Teva Pharmaceutical Industries Ltd. (TEVA) Gross margin
Teva Pharmaceutical Industries Ltd.'s gross margin over the twelve months to 30 September 2026 was 53.5%, up 1.7 percentage points from fiscal 2025 (51.8%). Over the past ten years it has ranged from 44.6% (fiscal 2019) to 57.8% (fiscal 2015); the current reading is higher than 82% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 53.5% and in line with the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 51.8% | 3.05 |
| FY2024 | 48.7% | 0.49 |
| FY2023 | 48.3% | 1.53 |
| FY2022 | 46.7% | (1.11) |
| FY2021 | 47.8% | 1.45 |
| FY2020 | 46.4% | 1.75 |
| FY2019 | 44.6% | (0.78) |
| FY2018 | 45.4% | (2.01) |
| FY2017 | 47.4% | (6.72) |
| FY2016 | 54.1% | (3.65) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 55.5% | 3.54 |
| Jun 2026 | 52.0% | 2.48 |
| Mar 2026 | 49.5% | (6.86) |
| Dec 2025 | 56.4% | 4.93 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.8% |
| UTHR United Therapeutics Corporation compare | 86.3% |
| ZTS Zoetis Inc. compare | 71.7% |
| TAK Takeda Pharmaceutical Co. compare | 65.9% |
| HLN Haleon PLC Sponsored ADR compare | 62.2% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| TEVA Teva Pharmaceutical Industries Ltd. | 53.5% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| VTRS Viatris Inc. compare | 35.3% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on TEVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement